Abiopharma

🔍 Hadlock Terrell Shane (Executive)

Company: Paycom Software, Inc. (PAYC)

Report Date: 2026-05-10

Detailed Transactions and Holdings:

• Sold 2,728 shares of Common Stock at $138.44 per share (Direct)
  Date: 2026-05-10 | Code: F | equity_swap_involved: false | shares_owned_after: 72,729.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents shares of common stock of Paycom Software, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of the following awards: (i) 225 shares of restricted stock granted to the reporting person on February 2, 2022; (ii) 209 shares of restricted stock granted to the reporting person on February 4, 2023; (iii) 1,250 shares of restricted stock granted to the reporting person on December 4, 2023; (iv) 287 shares of restricted stock granted to the reporting person on February 23, 2024; (v) 5,000 shares of restricted stock granted to the reporting person on October 18, 2024; and (vi) 1,258 shares of restricted stock granted to the reporting person on March 2, 2025. No shares were issued or sold in this transaction.
• F2: Includes 20,950 unvested restricted stock units and 12,936 unvested shares of restricted stock.